| Product Code: ETC335546 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Oestrogens and progestogens are hormones used in pharmaceuticals and hormone replacement therapies. The market outlook is tied to healthcare and pharmaceutical developments, including women`s health treatments and research on hormone-related conditions.
The Malaysia oestrogens and progestogens market outlook is shaped by the pharmaceutical and healthcare sectors. Oestrogens and progestogens are hormones used in hormone replacement therapy and contraceptives. Market growth is closely tied to developments in healthcare, including advancements in hormone therapy formulations and changing demographics. Regulatory changes and research into women`s health and hormone-related conditions also play a role in influencing market trends.
Challenges in the Malaysia oestrogens and progestogens market include evolving healthcare regulations and competition from generic medications. Regulatory changes related to pharmaceuticals can impact market access and pricing. Additionally, the availability of generic alternatives can affect the market for branded oestrogens and progestogens. Companies in this market must navigate regulatory complexities and focus on innovation and differentiation to maintain their competitive edge.
The market outlook for oestrogens and progestogens in Malaysia has been significantly influenced by the COVID-19 pandemic. While demand for hormone replacement therapy (HRT) products remained stable, disruptions in the global pharmaceutical supply chain led to sporadic shortages of these medications. The pandemic prompted a surge in telehealth services, driving the adoption of digital platforms for prescribing and monitoring hormone treatments, which may continue even as the situation normalizes.
The pharmaceutical industry in Malaysia might feature multinational companies such as Pfizer, Novartis, and GlaxoSmithKline, known for producing hormonal medications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Oestrogens And Progestogens Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Oestrogens And Progestogens Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Oestrogens And Progestogens Market - Industry Life Cycle |
3.4 Malaysia Oestrogens And Progestogens Market - Porter's Five Forces |
3.5 Malaysia Oestrogens And Progestogens Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malaysia Oestrogens And Progestogens Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Malaysia Oestrogens And Progestogens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about women's health and hormonal disorders |
4.2.2 Growing demand for hormone replacement therapy (HRT) |
4.2.3 Rising prevalence of menopausal symptoms and related disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of hormonal medications |
4.3.2 Concerns regarding potential side effects and safety of oestrogens and progestogens |
5 Malaysia Oestrogens And Progestogens Market Trends |
6 Malaysia Oestrogens And Progestogens Market, By Types |
6.1 Malaysia Oestrogens And Progestogens Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Aglepristone, 2021-2031F |
6.1.4 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Mifepristone, 2021-2031F |
6.1.5 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Asoprisnil, 2021-2031F |
6.1.6 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Telapristone, 2021-2031F |
6.1.7 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Ulipristal Acetate, 2021-2031F |
6.2 Malaysia Oestrogens And Progestogens Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Pharmacy, 2021-2031F |
6.2.3 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Hospital, 2021-2031F |
6.2.4 Malaysia Oestrogens And Progestogens Market Revenues & Volume, By Department Of Endocrinology, 2021-2031F |
7 Malaysia Oestrogens And Progestogens Market Import-Export Trade Statistics |
7.1 Malaysia Oestrogens And Progestogens Market Export to Major Countries |
7.2 Malaysia Oestrogens And Progestogens Market Imports from Major Countries |
8 Malaysia Oestrogens And Progestogens Market Key Performance Indicators |
8.1 Number of prescriptions for oestrogens and progestogens |
8.2 Patient adherence rates to HRT therapy |
8.3 Number of healthcare providers offering hormone replacement therapy services |
9 Malaysia Oestrogens And Progestogens Market - Opportunity Assessment |
9.1 Malaysia Oestrogens And Progestogens Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malaysia Oestrogens And Progestogens Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Malaysia Oestrogens And Progestogens Market - Competitive Landscape |
10.1 Malaysia Oestrogens And Progestogens Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Oestrogens And Progestogens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here